Chennai: The Tamil Nadu drug control administration has revoked the licences of 36 retailers and wholesalers across the state for selling habit-formin.

It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Viking Therapeutics' leading candidate, VK2735, is a potential GLP-1 weight loss medicine. It reported ...

Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

Novartis reported that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) reached its primary endpoint in a Phase III study in paediatric patients aged two to 17 with type II ...

In today’s fast-paced world, maintaining a healthy weight and efficient metabolism can often feel like an uphill battle. Many ...

The Centre has banned the manufacture, sale, and distribution of Nimesulide due to its toxicity to vultures. Studies showed that the drug caused elevated uric acid levels and kidney failure in ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

In the ever-evolving landscape of wellness products, Gentle Wave CBD Gummies stand out as a beacon of hope for those seeking ...

Regulators squeezed in two final approvals before the calendar change with the UK approval of Merck’s Winrevair and the FDA’s ...

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...

One could be forgiven for feeling the same way about the current world of drug delivery devices, with an increasingly ...